Skip to main content

Day: September 28, 2024

Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.

Written by Customer Service on . Posted in Mergers And Acquisitions.

/ Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, Sept. 28, 2024 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAF), a company focused on opportunities within and outside of the cannabis industry, announces that, further to its news release dated August 2, 2024, it has signed a definitive Business Combination Agreement (the “Agreement“) dated September 28, 2024 with 3Win Corp. (“3Win”) in respect of a transaction that would result in the reverse take-over (the “RTO”) of Digicann by 3Win (the “Proposed Transaction“) to ultimately form the resulting issuer (the “Resulting Issuer“). If completed, it is expected that the Proposed Transaction will constitute a “fundamental...

Continue reading

Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia

Written by Customer Service on . Posted in Public Companies.

Updated Phase 1 data presented at ESH-iCMLf 26th Annual John Goldman Conference Reported cumulative MMR rate of 44% (8/18) by 24 weeks, with stable or deepening responses between weeks 12 and 24, which continues to compare favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs ELVN-001 remains well-tolerated with no dose reductions reported with 39 patients enrolled and a median treatment duration of 20 weeks at cutoff BOULDER, Colo., Sept. 28, 2024 (GLOBE NEWSWIRE) — Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced updated, positive data from the Phase 1 clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia (CML) that has failed, or the patient is...

Continue reading

Nokia selected by Vodafone Idea as major 4G and 5G partner in India

Written by Customer Service on . Posted in Public Companies.

Press Release Nokia selected by Vodafone Idea as major 4G and 5G partner in India  Nokia and Vodafone Idea to deploy 5G network across major Indian cities; Deal includes modernizing and expanding the 4G network. Nokia to supply equipment from its energy-efficient AirScale portfolio including its MantaRay SON solution for network optimization and automation. Deal will bring premium connectivity to Vodafone Idea’s subscribers.28 September 2024Espoo, Finland – Nokia today announced that it has been awarded a three-year deal by Vodafone Idea Limited (VIL) to deploy 4G and 5G equipment. The agreement includes the modernization and expansion of VIL’s 4G network of which Nokia is already a major supplier. The deployment will deliver premium connectivity to 200 million VIL customers. Nokia will increase its market share and replace the incumbent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.